We are live on ! Find out more
SNOAW

Sonoma Pharmaceuticals, Inc. Warrants
SNOAW

Delisted

SNOAW was delisted on the 22nd of January, 2020.

Back to rankings

1 hedge funds and large institutions have $0 invested in Sonoma Pharmaceuticals, Inc. Warrants in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less capital invested

Capital invested by funds: $5K → $0 (-$5K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4K
2
UBS Group
UBS Group
Switzerland
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
– -$4K -27,867 Closed
UBS Group
2
UBS Group
Switzerland
– -$1K -7,000 Closed

SNOAW Hedge Fund Activity: Q3 2018 in Review

1 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q3 2018, worth a combined $0 — down 100% from $5K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SNOAW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $4K sold.

  • 1 institutional investor held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q3 2018, down from 3 in Q2 2018.
  • Funds reported $0 of Sonoma Pharmaceuticals, Inc. Warrants stock for Q3 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q3 2018 and 2 closed out, a net change of -2 holders.
  • The largest Sonoma Pharmaceuticals, Inc. Warrants seller in Q3 2018 was Susquehanna International Group, an estimated $4K sold.

Based on aggregated 13F filings for Q3 2018.